Literature DB >> 8315540

Barrett's esophagus: new definitions and approaches in children.

E Hassall1.   

Abstract

BE is a disorder that occurs in children likely as a consequence of prolonged GE reflux of gastroduodenal contents. It usually presents with complications of GE reflux, but it also may be relatively silent in childhood and then present with adenocarcinoma in childhood or present in adulthood. Although seldom recognized in children until relatively recently, it is being diagnosed with greater frequency but not always accurately. The diagnosis of BE can be made with certainty only if landmarks are carefully documented, and a detailed histologic map is made from multiple, large biopsies taken under direct vision at endoscopy; the diagnosis should be reserved for those patients where Barrett's specialized epithelium i.e., goblet cell metaplasia, is present. BE is a diagnosis that should be made with thorough documentation because of the implications for regression, cancer, and the need for follow-up and endoscopic biopsy surveillance. For treatment of complications and because there may be a chance for regression of a young (i.e., childhood) lesion, antireflux surgery or indefinite aggressive acid suppressing medical therapy is required. Because bile reflux may have a pathogenic role in BE, and because of the proven benefits of surgery in producing partial regression and prevention of dysphagia and cancer in some patients, the author's preference at present is for surgery. For children who are poor candidates for surgery, long-term omeprazole should be used (159). Adenocarcinoma does occur in childhood as a complication of BE. Because it can be recognized early, regular surveillance of children with bona fide BE is advisable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315540

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

1.  Time gated fluorescence spectroscopy in Barrett's oesophagus.

Authors:  M-A E J Ortner; B Ebert; E Hein; K Zumbusch; D Nolte; U Sukowski; J Weber-Eibel; B Fleige; M Dietel; M Stolte; G Oberhuber; R Porschen; B Klump; H Hörtnagl; H Lochs; H Rinneberg
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  Outcomes of fundoplication: causes for concern, newer options.

Authors:  E Hassall
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

Review 3.  Clinical implications of molecular changes in pediatric Barrett's esophagus.

Authors:  Licia Pensabene; Marta C Cohen; Michael Thomson
Journal:  Curr Gastroenterol Rep       Date:  2012-06

Review 4.  Gastroesophageal reflux in infants and children. When to reassure and when to go further.

Authors:  A B Jones
Journal:  Can Fam Physician       Date:  2001-10       Impact factor: 3.275

5.  Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients.

Authors:  Sandeep K Gupta; Eric Hassall; Yi-Lin Chiu; Fouad Amer; Melvin B Heyman
Journal:  Dig Dis Sci       Date:  2006-05-23       Impact factor: 3.199

Review 6.  Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children.

Authors:  S Cucchiara; M T Franco; G Terrin; R Spadaro; G di Nardo; V Iula
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

7.  Cost effectiveness of detecting Barrett's cancer.

Authors:  T A Wright; M R Gray; A I Morris; I T Gilmore; A Ellis; H L Smart; M Myskow; J Nash; R J Donnelly; A N Kingsnorth
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

8.  Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus.

Authors:  A P Weston; P T Krmpotich; R Cherian; A Dixon; M Topalovski
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

Review 9.  Step-up and step-down approaches to treatment of gastroesophageal reflux disease in children.

Authors:  Eric Hassall
Journal:  Curr Gastroenterol Rep       Date:  2008-06

10.  Barrett's esophagus in children: what is the evidence?

Authors:  Maja Raicevic; Amulya K Saxena
Journal:  World J Pediatr       Date:  2018-07-10       Impact factor: 2.764

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.